Cargando…
The impact of illness in patients with moderate to severe gastro-esophageal reflux disease
BACKGROUND: Gastro-esophageal reflux disease (GERD) is a common disease. It impairs health related quality of life (HRQL). However, the impact on utility scores and work productivity in patients with moderate to severe GERD is not well known. METHODS: We analyzed data from 217 patients with moderate...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1183201/ https://www.ncbi.nlm.nih.gov/pubmed/16004616 http://dx.doi.org/10.1186/1471-230X-5-23 |
_version_ | 1782124679408910336 |
---|---|
author | El-Dika, Samer Guyatt, Gordon H Armstrong, David Degl'innocenti, Alessio Wiklund, Ingela Fallone, Carlo A Tanser, Lisa van Zanten, Sander Veldhuyzen Heels-Ansdell, Diane Wahlqvist, Peter Chiba, Naoki Barkun, Alan N Austin, Peggy Schünemann, Holger J |
author_facet | El-Dika, Samer Guyatt, Gordon H Armstrong, David Degl'innocenti, Alessio Wiklund, Ingela Fallone, Carlo A Tanser, Lisa van Zanten, Sander Veldhuyzen Heels-Ansdell, Diane Wahlqvist, Peter Chiba, Naoki Barkun, Alan N Austin, Peggy Schünemann, Holger J |
author_sort | El-Dika, Samer |
collection | PubMed |
description | BACKGROUND: Gastro-esophageal reflux disease (GERD) is a common disease. It impairs health related quality of life (HRQL). However, the impact on utility scores and work productivity in patients with moderate to severe GERD is not well known. METHODS: We analyzed data from 217 patients with moderate to severe GERD (mean age 50, SD 13.7) across 17 Canadian centers. Patients completed three utility instruments – the standard gamble (SG), the feeling thermometer (FT), and the Health Utilities Index 3 (HUI 3) – and several HRQL instruments, including Quality of Life in Reflux and Dyspepsia (QOLRAD) and the Medical Outcomes Short Form-36 (SF-36). All patients received a proton pump inhibitor, esomeprazole 40 mg daily, for four to six weeks. RESULTS: The mean scores on a scale from 0 (dead) to 1 (full health) obtained for the FT, SG, and HUI 3 were 0.67 (95% CI, 0.64 to 0.70), 0.76 (95% CI, 0.75 to 0.80), and 0.80 (95% CI, 0.77 to 0.82) respectively. The mean scores on the SF-36 were lower than the previously reported Canadian and US general population mean scores and work productivity was impaired. CONCLUSION: GERD has significant impact on utility scores, HRQL, and work productivity in patients with moderate to severe disease. Furthermore, the FT and HUI 3 provide more valid measurements of HRQL in GERD than the SG. After treatment with esomeprazole, patients showed improved HRQL. |
format | Text |
id | pubmed-1183201 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-11832012005-08-06 The impact of illness in patients with moderate to severe gastro-esophageal reflux disease El-Dika, Samer Guyatt, Gordon H Armstrong, David Degl'innocenti, Alessio Wiklund, Ingela Fallone, Carlo A Tanser, Lisa van Zanten, Sander Veldhuyzen Heels-Ansdell, Diane Wahlqvist, Peter Chiba, Naoki Barkun, Alan N Austin, Peggy Schünemann, Holger J BMC Gastroenterol Research Article BACKGROUND: Gastro-esophageal reflux disease (GERD) is a common disease. It impairs health related quality of life (HRQL). However, the impact on utility scores and work productivity in patients with moderate to severe GERD is not well known. METHODS: We analyzed data from 217 patients with moderate to severe GERD (mean age 50, SD 13.7) across 17 Canadian centers. Patients completed three utility instruments – the standard gamble (SG), the feeling thermometer (FT), and the Health Utilities Index 3 (HUI 3) – and several HRQL instruments, including Quality of Life in Reflux and Dyspepsia (QOLRAD) and the Medical Outcomes Short Form-36 (SF-36). All patients received a proton pump inhibitor, esomeprazole 40 mg daily, for four to six weeks. RESULTS: The mean scores on a scale from 0 (dead) to 1 (full health) obtained for the FT, SG, and HUI 3 were 0.67 (95% CI, 0.64 to 0.70), 0.76 (95% CI, 0.75 to 0.80), and 0.80 (95% CI, 0.77 to 0.82) respectively. The mean scores on the SF-36 were lower than the previously reported Canadian and US general population mean scores and work productivity was impaired. CONCLUSION: GERD has significant impact on utility scores, HRQL, and work productivity in patients with moderate to severe disease. Furthermore, the FT and HUI 3 provide more valid measurements of HRQL in GERD than the SG. After treatment with esomeprazole, patients showed improved HRQL. BioMed Central 2005-07-10 /pmc/articles/PMC1183201/ /pubmed/16004616 http://dx.doi.org/10.1186/1471-230X-5-23 Text en Copyright © 2005 El-Dika et al; licensee BioMed Central Ltd. |
spellingShingle | Research Article El-Dika, Samer Guyatt, Gordon H Armstrong, David Degl'innocenti, Alessio Wiklund, Ingela Fallone, Carlo A Tanser, Lisa van Zanten, Sander Veldhuyzen Heels-Ansdell, Diane Wahlqvist, Peter Chiba, Naoki Barkun, Alan N Austin, Peggy Schünemann, Holger J The impact of illness in patients with moderate to severe gastro-esophageal reflux disease |
title | The impact of illness in patients with moderate to severe gastro-esophageal reflux disease |
title_full | The impact of illness in patients with moderate to severe gastro-esophageal reflux disease |
title_fullStr | The impact of illness in patients with moderate to severe gastro-esophageal reflux disease |
title_full_unstemmed | The impact of illness in patients with moderate to severe gastro-esophageal reflux disease |
title_short | The impact of illness in patients with moderate to severe gastro-esophageal reflux disease |
title_sort | impact of illness in patients with moderate to severe gastro-esophageal reflux disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1183201/ https://www.ncbi.nlm.nih.gov/pubmed/16004616 http://dx.doi.org/10.1186/1471-230X-5-23 |
work_keys_str_mv | AT eldikasamer theimpactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT guyattgordonh theimpactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT armstrongdavid theimpactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT deglinnocentialessio theimpactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT wiklundingela theimpactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT fallonecarloa theimpactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT tanserlisa theimpactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT vanzantensanderveldhuyzen theimpactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT heelsansdelldiane theimpactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT wahlqvistpeter theimpactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT chibanaoki theimpactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT barkunalann theimpactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT austinpeggy theimpactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT schunemannholgerj theimpactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT eldikasamer impactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT guyattgordonh impactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT armstrongdavid impactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT deglinnocentialessio impactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT wiklundingela impactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT fallonecarloa impactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT tanserlisa impactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT vanzantensanderveldhuyzen impactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT heelsansdelldiane impactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT wahlqvistpeter impactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT chibanaoki impactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT barkunalann impactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT austinpeggy impactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease AT schunemannholgerj impactofillnessinpatientswithmoderatetoseveregastroesophagealrefluxdisease |